Investment analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a research report issued on Thursday. The firm set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Stock Up 4.4 %
Shares of NASDAQ RKDA opened at $6.36 on Thursday. The business has a 50-day moving average price of $4.61 and a 200 day moving average price of $3.53. The stock has a market cap of $8.68 million, a PE ratio of -1.49 and a beta of 1.19. Arcadia Biosciences has a 52-week low of $1.85 and a 52-week high of $10.31.
About Arcadia Biosciences
Read More
- Five stocks we like better than Arcadia Biosciences
- There Are Different Types of Stock To Invest In
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- What Are Earnings Reports?
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Why is the Ex-Dividend Date Significant to Investors?
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.